Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes

Fig. 2

Trend of HbA1c, LDL-cholesterol, and BMI in the three groups during follow-up. Graphs showing the mean values of glycated haemoglobin (HbA1c) (A), LDL-cholesterol (C), and BMI (D), along with the mean cumulative HbA1c (B), in the three groups during the successive visits of the follow-up. Error bars are ± SE for panels A, C, and D. *P < 0.05 SGLT-2i/GLP-1RA vs SGLT-2i; †P < 0.05 SGLT-2i/GLP-1RA vs GLP-1RA; ⁋P < 0.05 SGLT-2i vs SGLT-2i/GLP-1RA; §P < 0.05 SGLT-2i vs GLP-1RA; Kruskal–Wallis followed by Dunn’s test for all. Boxplots show the median, 25th, and 75th percentiles, range, and extreme values

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840